Research findings from Lifespan health system, based in Providence, R.I., showed that a molecular method detects significantly more cases of C. diff than other methods, according to a health system news release.
For the study, five different assays were compared in the health system laboratory for identifying C. diff. Researchers then evaluated the result of molecular versus non-molecular tests. Results showed the molecular methods detected 35-54 percent more patients who were positive for C. diff than non-molecular tests.
Read the news release about the Lifespan study on molecular tests for C. diff infections.
Related Articles on C. Diff:
New Policies at Texas VA Hospital Lead to 82% Decrease of Infection by Multidrug-Resistant Organisms
C. Diff Increases Risk of Death 6-Fold in Inflammatory Bowel Disease Patients
Wound Dressing With Silver Kills MRSA, Other Antibiotic-Resistance 'Superbugs'
For the study, five different assays were compared in the health system laboratory for identifying C. diff. Researchers then evaluated the result of molecular versus non-molecular tests. Results showed the molecular methods detected 35-54 percent more patients who were positive for C. diff than non-molecular tests.
Read the news release about the Lifespan study on molecular tests for C. diff infections.
Related Articles on C. Diff:
New Policies at Texas VA Hospital Lead to 82% Decrease of Infection by Multidrug-Resistant Organisms
C. Diff Increases Risk of Death 6-Fold in Inflammatory Bowel Disease Patients
Wound Dressing With Silver Kills MRSA, Other Antibiotic-Resistance 'Superbugs'